Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2016   |   Volume: 5   |   Issue: 1   |   Page: 76-78     View issue

Nab-paclitaxel as induction chemotherapy in external auditory canal carcinoma: Case report and review of literature


, , , , ,
Abstract

Squamous cell carcinoma of the external auditory canal, middle ear, and temporal bone is a rare and unusual malignancy. The rare occurrence of the disease makes the formulation of uniform treatment guidelines and appropriate management challenging. The role of chemotherapy in this disease is not clearly defined in literature. We describe a clinical case of a patient with this rare malignancy and an excellent response achieved with nanoparticle - albumin-bound paclitaxel and present a comprehensive review of literature.

Cite this article
Vancouver
Shrivastava A, Mandloi V, Tiwari V, Ghori H, Singh O, Yogi V. Nab-paclitaxel as induction chemotherapy in external auditory canal carcinoma: Case report and review of literature. Clin Cancer Investig J. 2016;5(1):76-8. https://doi.org/10.4103/2278-0513.172077
APA
Shrivastava, A., Mandloi, V., Tiwari, V., Ghori, H., Singh, O., & Yogi, V. (2016). Nab-paclitaxel as induction chemotherapy in external auditory canal carcinoma: Case report and review of literature. Clinical Cancer Investigation Journal, 5(1), 76-78. https://doi.org/10.4103/2278-0513.172077

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513